TrianglePUBLICATIONS · 24938649
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 2015 Feb
- First author
- Satwani P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Satwani P
- type
- Author
- name
- Jin Z
- type
- Author
- name
- Martin PL
- type
- Author
- name
- Bhatia M
- type
- Author
- name
- Garvin JH
- type
- Author
- name
- George D
- type
- Author
- name
- Chaudhury S
- type
- Author
- name
- Talano J
- type
- Author
- name
- Morris E
- type
- Author
- name
- Harrison L
- type
- Author
- name
- Sosna J
- type
- Author
- name
- Peterson M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Satwani P
- type
- Author
- name
- Jin Z
- type
- Author
- name
- Martin PL
- type
- Author
- name
- Bhatia M
- type
- Author
- name
- Garvin JH
- type
- Author
- name
- George D
- type
- Author
- name
- Chaudhury S
- type
- Author
- name
- Talano J
- type
- Author
- name
- Morris E
- type
- Author
- name
- Harrison L
- type
- Author
- name
- Sosna J
- type
- Author
- name
- Peterson M
- type
- Author
- bibliography ids
- nci-bib-ef7f79c6356304e41374684b
- book metadata
- content sha256
- 0cca711c9b77679a3305b358611bb7660b5e89dd9a3685f864540a42cb37e6e1
- document type
- citation
- dois
- 10.1038/leu.2014.194
- electronic publication date
- display
- 2014 Jun 18
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24938649
- immutable id
- pubmed:24938649@0cca711c9b77679a3305b358611bb7660b5e89dd9a3685f864540a42cb37e6e1
- journal
- abbreviation
- Leukemia
- issn electronic
- 1476-5551
- issn print
- 0887-6924
- issue
- 2
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 448-55
- volume
- 29
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24938649
- provenance
- batch id
- 69903be8ceab8801c81a
- provider
- NCBI PubMed ESummary
- record sha256
- 56389b07e23e958ba5faf37d93d5de17f107aade7567663c167d24a3ca1e327e
- response sha256
- 1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
- retrieved at
- 2026-09-09T23:47:05.208886+00:00
- publication date
- display
- 2015 Feb
- precision
- month
- year
- 2015
- publication types
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.
Preserved source evidence · Not medical advice